Definitive Contract HHSN261201000040C

Ended Awarded Last action

Contract number
HHSN261201000040C
Awardee
Awarding agency
Obligated
$185,116

Award facts

Contract value 100% obligated
$185,116.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Clayton, MO 63124, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $185,116

About this award

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract, valued at $185,116, is a firm-fixed-price definitive contract for research and development work. The contract was awarded on September 24, 2010 and has an ultimate completion date of June 23, 2011. As an SBIR Phase I contract, it is focused on the early-stage feasibility study of a technology or product, which is typical of the SBIR program's goal of supporting small businesses in developing innovative solutions.

Quick answers

Who was awarded contract HHSN261201000040C?

HHSN261201000040C was awarded to Mediomics LLC by National Cancer Institute (National Institutes of Health) on September 24, 2010.

How much is contract HHSN261201000040C worth?

The government has obligated $185,116 on HHSN261201000040C.

Was contract HHSN261201000040C competed?

The extent of competition for HHSN261201000040C was full and open competition after exclusion of sources. The government received 4 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award